Zoll Defibrillator Sales Growth, Upcoming Public AED Entry Buoy Stock In July
This article was originally published in The Gray Sheet
Executive Summary
Zoll Medical's upcoming entry into the public access automated external defibrillator (AED) market, coupled with revived sales growth in its third fiscal quarter, helped the firm's stock jump ahead 33% in July. The issue closed at $36.45, up $9 for the month.